These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 27499269)

  • 1. Nanoscale studies link amyloid maturity with polyglutamine diseases onset.
    Ruggeri FS; Vieweg S; Cendrowska U; Longo G; Chiki A; Lashuel HA; Dietler G
    Sci Rep; 2016 Aug; 6():31155. PubMed ID: 27499269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibril polymorphism affects immobilized non-amyloid flanking domains of huntingtin exon1 rather than its polyglutamine core.
    Lin HK; Boatz JC; Krabbendam IE; Kodali R; Hou Z; Wetzel R; Dolga AM; Poirier MA; van der Wel PCA
    Nat Commun; 2017 May; 8():15462. PubMed ID: 28537272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Liquid to Solid Phase Transition Underlying Pathological Huntingtin Exon1 Aggregation.
    Peskett TR; Rau F; O'Driscoll J; Patani R; Lowe AR; Saibil HR
    Mol Cell; 2018 May; 70(4):588-601.e6. PubMed ID: 29754822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploding the Repeat Length Paradigm while Exploring Amyloid Toxicity in Huntington's Disease.
    Wetzel R
    Acc Chem Res; 2020 Oct; 53(10):2347-2357. PubMed ID: 32975927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy preferentially degrades non-fibrillar polyQ aggregates.
    Zhao DY; Bäuerlein FJB; Saha I; Hartl FU; Baumeister W; Wilfling F
    Mol Cell; 2024 May; 84(10):1980-1994.e8. PubMed ID: 38759629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folding Landscape of Mutant Huntingtin Exon1: Diffusible Multimers, Oligomers and Fibrils, and No Detectable Monomer.
    Sahoo B; Arduini I; Drombosky KW; Kodali R; Sanders LH; Greenamyre JT; Wetzel R
    PLoS One; 2016; 11(6):e0155747. PubMed ID: 27271685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggregation landscapes of Huntingtin exon 1 protein fragments and the critical repeat length for the onset of Huntington's disease.
    Chen M; Wolynes PG
    Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4406-4411. PubMed ID: 28400517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of Chaperone-Mediated Effects on Polyglutamine Protein Aggregation by the Filter Trap Assay.
    van Waarde-Verhagen MAWH; Kampinga HH
    Methods Mol Biol; 2018; 1709():59-74. PubMed ID: 29177651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calmidazolium Chloride and Its Complex with Serum Albumin Prevent Huntingtin Exon1 Aggregation.
    Singh V; Deepak RNVK; Sengupta B; Joshi AS; Fan H; Sen P; Thakur AK
    Mol Pharm; 2018 Aug; 15(8):3356-3368. PubMed ID: 29979597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Targetable Self-association Surface of the Huntingtin exon1 Helical Tetramer Required for Assembly of Amyloid Pre-nucleation Oligomers.
    Mishra R; Gerlach GJ; Sahoo B; Camacho CJ; Wetzel R
    J Mol Biol; 2024 Jun; 436(12):168607. PubMed ID: 38734203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of mutant Huntingtin aggregates and toxicity by human myeloid leukemia factors.
    Banerjee M; Datta M; Bhattacharyya NP
    Int J Biochem Cell Biol; 2017 Jan; 82():1-9. PubMed ID: 27840155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding, internalization and fate of Huntingtin Exon1 fibrillar assemblies in mitotic and nonmitotic neuroblastoma cells.
    Ruiz-Arlandis G; Pieri L; Bousset L; Melki R
    Neuropathol Appl Neurobiol; 2016 Feb; 42(2):137-52. PubMed ID: 26111612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insights into the aggregation mechanism of huntingtin exon 1 protein fragment with different polyQ-lengths.
    Priya SB; Gromiha MM
    J Cell Biochem; 2019 Jun; 120(6):10519-10529. PubMed ID: 30672003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-state nuclear magnetic resonance in the structural study of polyglutamine aggregation.
    van der Wel PCA
    Biochem Soc Trans; 2024 Apr; 52(2):719-731. PubMed ID: 38563485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous self-assembly of pathogenic huntingtin exon 1 protein into amyloid structures.
    Trepte P; Strempel N; Wanker EE
    Essays Biochem; 2014; 56():167-80. PubMed ID: 25131594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyglutamine induced misfolding of huntingtin exon1 is modulated by the flanking sequences.
    Lakhani VV; Ding F; Dokholyan NV
    PLoS Comput Biol; 2010 Apr; 6(4):e1000772. PubMed ID: 20442863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis implicates the amyloid fibril as the toxic entity in Huntington's disease.
    Drombosky KW; Rode S; Kodali R; Jacob TC; Palladino MJ; Wetzel R
    Neurobiol Dis; 2018 Dec; 120():126-138. PubMed ID: 30171891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMOylation Prevents Huntingtin Fibrillization and Localization onto Lipid Membranes.
    Sedighi F; Adegbuyiro A; Legleiter J
    ACS Chem Neurosci; 2020 Feb; 11(3):328-343. PubMed ID: 31880908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Basis of Huntingtin Fibril Polymorphism Revealed by Cryogenic Electron Microscopy of Exon 1 HTT Fibrils.
    Nazarov S; Chiki A; Boudeffa D; Lashuel HA
    J Am Chem Soc; 2022 Jun; 144(24):10723-10735. PubMed ID: 35679155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 17-residue-long N terminus in huntingtin controls stepwise aggregation in solution and on membranes via different mechanisms.
    Pandey NK; Isas JM; Rawat A; Lee RV; Langen J; Pandey P; Langen R
    J Biol Chem; 2018 Feb; 293(7):2597-2605. PubMed ID: 29282287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.